Register Here

2020 Executive Sponsors

BD Medical
Credence Medsystems

2020 Associate Sponsors

Cambridge Design Partnership
EdgeOne Medical

2020 Technology Sponsors

BDD Pharma
Common Sensing
Gerresheimer Medical Systems
InnoCore Pharmaceuticals
Key Tech
Lyndra Therapeutics
Portal Instruments
Sensile Medical
SHL Group
Sorrel Medical
Stevanato Group

2020 Showcase Sponsors

Baumann Group

2020 Soapbox Sponsors

Libera Bio

2020 Supporting Sponsors

Drug Delivery Experts

2020 Media Partners

Drug Development and Delivery
Med Device Online
Pharmaceutical Online


Partnership Opportunities in Drug Delivery (PODD) is celebrating its 10th anniversary event virtually. Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, and small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations. 

Presenting PODD Virtually 

As the vaccine for COVID-19 is not expected to arrive in 2020, our choices for responsible conferences will be in virtual formats. It is our job to make sure that when you attend PODD, it provides an excellent virtual experience with the most relevant content, an excellent speaking faculty and the latest information on a wide range of drug delivery technologies. It is our job to provide you with a first rate platform, a reliable partnering tool, virtual networking and above all a valuable experience! 

2020 Co-Chairs & Keynotes

PODD 2020 Co-Chairs and Keynotes

2020 Featured Speakers

Key Topic Areas for 2020

  • Long-Acting Injectables:  Therapeutics Needs and Strategic Considerations
  • Critical Development Issues for Subcutaneous Delivery
  • Patient Experience Using Novel Drug Delivery Products
  • Connected Health Devices: Key Success Factors and Lessons Learned
  • Oral Protein & Peptide Delivery: Clinical Success and Future Opportunities
  • Unlocking the Potential of Gene Delivery Systems
  • Targeting the BBB: Innovations Making Progress in the Treatment of CNS Disorders
  • Next-Generation Injectables: Microneedles, Intradermal Injectors, Advanced Needle Technologies
  • Pharma Partnering and Current Role of Drug Delivery
  • Additional topics TBA


Additional Program Features

  • Pharma Company Spotlights on Drug Delivery Needs and Partnering Philosophies
  • Technology Presentations – 6 Tracks Covering a Wide Range of Drug Delivery Technologies
  • Partnering Opportunities that include One-on-One Scheduled Meetings to Help Foster New Collaborations
  • Exhibit Hall featuring 50+ vendors, showcasing drug delivery products and services


The PODD promise:

  1. Present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.

  2. Provide drug delivery and specialty pharmas with a platform to present their technologies.

  3. Offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.

The agenda is published and we will continue to add more speakers and sessions throughout.  For any questions, please contact us at



Valerie Bowling New

Valerie Bowling
Executive Director


Meredith Sands
Executive Director, Business Development

Michelle McDermott
Senior Drug Delivery Advisor


Meg Gould
Senior Conference Planner

Bre Bugbee
Marketing Manager

Efrosini Zambas
Assistant Meeting Planner

A Note on the Growth of the Drug Delivery Industry 

The drug delivery industry is expected to experience robust growth to exceed more than $1,900 Billion by 2024. The key reasons for growth include: drug innovation and technological advancements, new drug products, growth of biologics, chronic diseases and the growth of the geriatric population.

Often, the most complex part of developing a therapeutic is to design an appropriate delivery system for it. The use of drug delivery technologies will continue to rise, as the industry focuses on more cost-effective, targeted, and patient-centered therapies.


  • "Incredible! Fantastic overview of the industry, recent, partnerships and opportunities for the future. Helpful input on panels, speaker presentations and what's in the pipeline. Great networking opportunities and sharing insights with colleagues. Hard to choose just one area - was all invaluable."

    - Kristin King, Rogers Sciences

  • "Overall very satisfied. Best was networking, coming across new technologies that I did not necessarily have on the radar, and the speaker’s program."

    - Gregoire Schwach, Roche

  • "Was a great conference and getting better every year!"

    - Rudy Emmelot, IntraTab Labs

  • "I have to say PODD was a great opportunity for me. I learned a lot and met great people. Thanks to The Conference Forum."

    - Sina Eetezadi, Roche Pharmaceuticals

  • "This was a great partnering event for us. In addition to our product development services, we have a couple of proprietary technologies that we are promoting. The right group of Directors, Exec Dir, VPs were at the meeting who were all looking for delivery technologies."

    - Chris Rhodes, Drug Delivery Experts